Target intelligence / Profile preview

Nudix hydrolase 4 pseudogene 2 (NUDT4P2)

Target
NUDT4P2
Molecular classification
Other (Pseudogene)
01

Overview

Nudix hydrolase 4 pseudogene 2 (NUDT4P2) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to that of a functional gene (likely NUDT4) but is generally considered non-functional due to disabling mutations or lack of expression[1][5]. There is no evidence that NUDT4P2 produces a functional protein, nor is it recognized as a therapeutic target or involved in any molecular pathways or disease mechanisms. Pseudogenes like NUDT4P2 are sometimes studied for their evolutionary or regulatory significance but are not themselves considered molecular targets[3][5]. No interacting drugs, mechanisms of action, or biomarker evidence exist for NUDT4P2, and there are no unique aliases or alternative names reported. Special note: - NUDT4P2 is easily confused with genuine functional "nudix hydrolase" family members such as NUDT2 or NUDT4, both of which are active enzymes with defined biological roles[2][4]. However, NUDT4P2 itself is a pseudogene and should not be mistaken for these active hydrolases. - There are no current reports or evidence of NUDT4P2 functioning in transcription, mRNA decapping, disease progression, or therapeutic applications. Conclusion: NUDT4P2 is a pseudogene and not an actionable biomedical or therapeutic target. If a functional nudix hydrolase (such as NUDT2 or NUDT4) is intended, clarification or correction of the query is needed.

Beyond the preview

Go deeper on Nudix hydrolase 4 pseudogene 2 (NUDT4P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nudix hydrolase 4 pseudogene 2 (NUDT4P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call